The TenoTac 2.0 Soft Tissue Fixation System uses a titanium threaded implant and was designed to allow for greater capture of soft tissue, streamlined tensioning, and improved fit to the bony surface
TenoTac 2.0 Soft Tissue Stabilization System (Credit: Business Wire/ Paragon 28, Inc.)
Paragon 28, a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac 2.0 Soft Tissue Fixation System. The TenoTac 2.0 Soft Tissue Fixation System uses a titanium threaded implant and was designed to allow for greater capture of soft tissue, streamlined tensioning, and improved fit to the bony surface.
Paragon 28’s CEO, Albert DaCosta, commented, “With the launch of TenoTac 2.0, we further refined our initial offering to allow surgeons greater control and precision to address the unique needs of each patient. TenoTac 2.0 adds to our growing portfolio of soft tissue products and the Hammertoe segment, with opportunities for significant improvements in patient outcomes.”
The addition of the TenoTac 2.0 Soft Tissue Fixation System bolsters Paragon 28’s hammertoe product offering, which includes the Paratrooper Plantar Plate System, HammerTube Hammertoe System, Mini-Monster Screw System, and JAWS Staple System. With this comprehensive portfolio, Paragon 28 provides its customers innovative forefoot solutions to address flexible and rigid contractures of the lesser toes.
Source: Company Press Release